Internal Medicine, Hematology & Oncology · Denver, CO
NPI
1538107149
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2045 N Franklin St
Denver, CO, 80205
Phone (303) 338-4545
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
2,567 services
Medicare patients, 2024
24
Average age 65
Drug cost, 2024
$1.7M
867 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Lala A Cornelius prescribed most often to Medicare patients was Letrozole, with 84 prescriptions and refills. In total Lala A Cornelius wrote 867 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Letrozole Generic | 84 | 184 | 25 | $1,377 |
| Tamoxifen Citrate Generic | 81 | 178 | 23 | $1,491 |
| Anastrozole Generic | 60 | 164 | 22 | $1,558 |
| Acyclovir Generic | 56 | 138 | 22 | $1,446 |
| Potassium Chloride Generic | 38 | 57 | 16 | $660 |
| Hydroxyurea Generic | 35 | 92 | 11 | $1,655 |
| Imatinib Mesylate Generic | 33 | 33 | Under 11 | $1,647 |
| Lenalidomide Generic | 31 | 31 | Under 11 | $362K |
| Omeprazole Generic | 25 | 44 | 12 | $362 |
| Xarelto Rivaroxaban | 25 | 40 | Under 11 | $19K |
| Prednisone Generic | 23 | 23 | 11 | $161 |
| Eliquis Apixaban | 22 | 48 | Under 11 | $30K |
| Dexamethasone Generic | 21 | 21 | 12 | $230 |
| Ondansetron Odt Ondansetron | 18 | 18 | 16 | $191 |
| Venclexta Venetoclax | 18 | 18 | Under 11 | $183K |
Brand drugs: - claims; generic drugs: 682 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lala A Cornelius were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.